Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Population pharmacokinetic-pharmacodynamic (PKPD) modeling of ibrutinib in patients with B-cell malignancies. Poggesi, I., Sardu, M., Marostica, E., Sukbuntherng, J., Chang, B. Y., de Jong, J., de Trixhe, X., Vermeulen, A., De Nicolao, G., O'Brien, S., Byrd, J. C., Advani, R. H., James, D., Deraedt, W., Beaupre, D., Wang, M. AMER ASSOC CANCER RESEARCH. 2015
View details for DOI 10.1158/1557-3265.HEMMAL14-B19
View details for Web of Science ID 000361386200055